ArticleScientific reports2026
Interface improvement and multiscale assessment of recycled concrete aggregates with epoxy resin polymer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and properties of composite coatings for surface repair of cement concrete pavements.Scientific reports · 2026Article
- Effect of graphene nanoplatelets on the behaviour of cementitious compounds: an experimental investigation.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recycled concrete aggregate (RCA) exhibits challenges like weak bonding, high porosity, and inferior strength compared to natural aggregates. This study evaluates the effect of epoxy resin polymer treatment on RCA on enhancing compressive and split tensile strengths in concrete, replacing natural aggregates with untreated RCA (UTRAC) and treated RCA (ERTAC) at 25%, 50%, 75%, and 100% levels. The tests were conducted at 3, 7, and 28 days. UTRAC showed reductions of up to 26.32% in compressive strength and 35.38% in tensile strength at 100% replacement; ERTAC outperformed control concrete (CC) with gains of up to 26.32% in compressive strength (at 25%) and 122.73% in tensile strength (at 100%), identifying 25% as the optimum replacement ratio. SEM and XRD analyses confirmed improved particle packing, reduced porosity, and stronger interfacial transition zones (ITZ) in ERTAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.